Sujith Samarasinghe

Seattle Children's Hospital — United States

Medicine · Health Sciences

36h-index6.1kcitations134works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(49), Hematopoietic Stem Cell Transplantation(31), Childhood Cancer Survivors' Quality of Life(28), CAR-T cell therapy research(25), Acute Myeloid Leukemia Research(21)

Publications134 total

OUTCOMES OF IMMUNOSUPPRESSIVE AND TRANSPLANT THERAPIES IN PEDIATRIC PATIENTS WITH MODERATE APLASTIC ANEMIA: A SYSTEMATIC LITERATURE REVIEW
EJC Paediatric Oncology·2025Open Access
SINGLE CENTRE EXPERIENCE IN TREATING PAEDIATRIC HIGH RISK (MYC REARRANGED OR HIGH STAGE) POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) USING INTERMEDIATE INTENSITY R-GRAB PROTOCOL
Leukemia Research·2025
Late Onset Blinatumomab‐Related Neurotoxicity in a Child With B‐Cell Acute Lymphoblastic Leukemia
Pediatric Blood & Cancer·2025· 1 cited
Blinatumomab in Childhood B-Cell Acute Lymphoblastic Leukemia
New England Journal of Medicine·2025
Late Onset Blinatumomab-Related Neurotoxicity in a Child with B-Cell Acute Lymphoblastic Leukemia
2025Open Access
High-Dose Methotrexate in Children and Young Adults With ALL and Lymphoblastic Lymphoma: Results of the Randomized Phase III Study UKALL 2011
Journal of Clinical Oncology·2025· 7 citedOpen Access
Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial
Blood Advances·2025· 3 citedOpen Access
Childhood acute lymphoblastic leukaemia
2025
How to use monoclonal antibody-based therapy in ALL
EJC Paediatric Oncology·2025· 2 citedOpen Access
Bridging Pediatric B-Cell Acute Lymphoblastic Leukemia (ALL) Patients to CAR-T Cell Therapy: A National Perspective
Blood·2024
Abstract B030: Whole genome sequencing provides practice-changing benefits when performed on consecutive, unselected children with suspected cancer
Cancer Research·2024
Outcomes of hematopoietic stem cell transplantation in 813 pediatric patients with Fanconi anemia
Blood·2024· 20 cited
Benefits for children with suspected cancer from routine whole-genome sequencing
Nature Medicine·2024· 32 citedOpen Access
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme
Blood Cancer Journal·2024· 15 citedOpen Access
Donor-type bone marrow aplasia following hematopoietic stem cell transplantation in a child with a novel <i>SAMD9L</i> variant
Hematology·2024· 1 citedOpen Access
Risk factors for oral cancers among patients in western province: a matched case-control study
2024
An Overview of the Genetics and Treatment of Down Syndrome ALL
Pediatric oncology·2024
Scylla and Charybdis: Unpalatable choices in managing hypodiploid acute lymphoblastic leukemia
EJC Paediatric Oncology·2023· 1 citedOpen Access
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL
Journal of Clinical Oncology·2023· 53 cited
Title: Risk Factors and Natural History of Vincristine Induced Neuropathy on UKALL 2011: A Randomised Controlled Trial of the Effect of Omitting Vincristine Pulses
Blood·2023Open Access
page 1 of 7Next →

Frequent Co-authors

Ajay Vora(23), Paul Veys(16), Persis Amrolia(12), Jack Bartram(12), Rachael Hough(12), David O’Connor(10), Sara Ghorashian(9), Giovanna Lucchini(8), Robert Wynn(7), Anupama Rao(7), John Moppett(7), Vesna Pavasovic(7), Stuart Adams(6), Danielle Pinner(6), Kimberly Gilmour(6), Sarah Inglott(6), Robert Chiesa(6), Judith Marsh(6), Kanchan Rao(6), Denise Bonney(6)